|
FDA OKs New Maintenance Asthma Treatment Arnuity Ellipta
Medscape Other important safety information included in the highlights section of the prescribing information includes the following: "Arnuity Ellipta is contraindicated for primary treatment of status asthmaticus or acute episodes of asthma requiring intensive … |
View full post on asthma – Google News